Cargando…

Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development

[Image: see text] Fasciola hepatica, the common liver fluke and causative agent of zoonotic fasciolosis, impacts on food security with global economic losses of over $3.2 BN per annum through deterioration of animal health, productivity losses, and livestock death and is also re-emerging as a foodbo...

Descripción completa

Detalles Bibliográficos
Autores principales: Collett, Clare F., Phillips, Helen C., Fisher, Maggie, Smith, Sian, Fenn, Caroline, Goodwin, Phil, Morphew, Russell M., Brophy, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361350/
https://www.ncbi.nlm.nih.gov/pubmed/35849550
http://dx.doi.org/10.1021/acs.jproteome.2c00299
_version_ 1784764513880375296
author Collett, Clare F.
Phillips, Helen C.
Fisher, Maggie
Smith, Sian
Fenn, Caroline
Goodwin, Phil
Morphew, Russell M.
Brophy, Peter M.
author_facet Collett, Clare F.
Phillips, Helen C.
Fisher, Maggie
Smith, Sian
Fenn, Caroline
Goodwin, Phil
Morphew, Russell M.
Brophy, Peter M.
author_sort Collett, Clare F.
collection PubMed
description [Image: see text] Fasciola hepatica, the common liver fluke and causative agent of zoonotic fasciolosis, impacts on food security with global economic losses of over $3.2 BN per annum through deterioration of animal health, productivity losses, and livestock death and is also re-emerging as a foodborne human disease. Cathepsin proteases present a major vaccine and diagnostic target of the F. hepatica excretory/secretory (ES) proteome, but utilization in diagnostics of the highly antigenic zymogen stage of these proteins is surprisingly yet to be fully exploited. Following an immuno-proteomic investigation of recombinant and native procathepsins ((r)FhpCL1), including mass spectrometric analyses (DOI: 10.6019/PXD030293), and using counterpart polyclonal antibodies to a recombinant mutant procathepsin L (anti-rFhΔpCL1), we have confirmed recombinant and native cathepsin L zymogens contain conserved, highly antigenic epitopes that are conformationally dependent. Furthermore, using diagnostic platforms, including pilot serum and fecal antigen capture enzyme-linked immunosorbent assay (ELISA) tests, the diagnostic capacities of cathepsin L zymogens were assessed and validated, offering promising efficacy as markers of infection and for monitoring treatment efficacy.
format Online
Article
Text
id pubmed-9361350
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-93613502022-08-10 Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development Collett, Clare F. Phillips, Helen C. Fisher, Maggie Smith, Sian Fenn, Caroline Goodwin, Phil Morphew, Russell M. Brophy, Peter M. J Proteome Res [Image: see text] Fasciola hepatica, the common liver fluke and causative agent of zoonotic fasciolosis, impacts on food security with global economic losses of over $3.2 BN per annum through deterioration of animal health, productivity losses, and livestock death and is also re-emerging as a foodborne human disease. Cathepsin proteases present a major vaccine and diagnostic target of the F. hepatica excretory/secretory (ES) proteome, but utilization in diagnostics of the highly antigenic zymogen stage of these proteins is surprisingly yet to be fully exploited. Following an immuno-proteomic investigation of recombinant and native procathepsins ((r)FhpCL1), including mass spectrometric analyses (DOI: 10.6019/PXD030293), and using counterpart polyclonal antibodies to a recombinant mutant procathepsin L (anti-rFhΔpCL1), we have confirmed recombinant and native cathepsin L zymogens contain conserved, highly antigenic epitopes that are conformationally dependent. Furthermore, using diagnostic platforms, including pilot serum and fecal antigen capture enzyme-linked immunosorbent assay (ELISA) tests, the diagnostic capacities of cathepsin L zymogens were assessed and validated, offering promising efficacy as markers of infection and for monitoring treatment efficacy. American Chemical Society 2022-07-18 2022-08-05 /pmc/articles/PMC9361350/ /pubmed/35849550 http://dx.doi.org/10.1021/acs.jproteome.2c00299 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Collett, Clare F.
Phillips, Helen C.
Fisher, Maggie
Smith, Sian
Fenn, Caroline
Goodwin, Phil
Morphew, Russell M.
Brophy, Peter M.
Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development
title Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development
title_full Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development
title_fullStr Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development
title_full_unstemmed Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development
title_short Fasciola hepatica Cathepsin L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific Conformational Epitopes to Support Diagnostics Development
title_sort fasciola hepatica cathepsin l zymogens: immuno-proteomic evidence for highly immunogenic zymogen-specific conformational epitopes to support diagnostics development
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361350/
https://www.ncbi.nlm.nih.gov/pubmed/35849550
http://dx.doi.org/10.1021/acs.jproteome.2c00299
work_keys_str_mv AT collettclaref fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment
AT phillipshelenc fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment
AT fishermaggie fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment
AT smithsian fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment
AT fenncaroline fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment
AT goodwinphil fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment
AT morphewrussellm fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment
AT brophypeterm fasciolahepaticacathepsinlzymogensimmunoproteomicevidenceforhighlyimmunogeniczymogenspecificconformationalepitopestosupportdiagnosticsdevelopment